1. Home
  2. ELUT
  3. ELUT News

Latest Elutia Inc. (ELUT) News on October 31, 2025

Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
ELUT

GlobeNewswire

8 days ago

Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Tracking the Evolving Story for Elutia After the BioEnvelope Sale
ELUT

Simply Wall St.

13 days ago

Tracking the Evolving Story for Elutia After the BioEnvelope Sale

Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
ELUT

GlobeNewswire

17 days ago

Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21

Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors
ELUT

GlobeNewswire

21 days ago

Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors

Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards
ELUT

GlobeNewswire

4 months ago

Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards

Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method
ELUT

GlobeNewswire

5 months ago

Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method

Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales
ELUT

GlobeNewswire

6 months ago

Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales

Elutia Inc (ELUT) Q1 2025: Everything You Need To Know Ahead Of Earnings
ELUT

GuruFocus.com

6 months ago

Elutia Inc (ELUT) Q1 2025: Everything You Need To Know Ahead Of Earnings

Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio
ELUT

GlobeNewswire

6 months ago

Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio

Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025
ELUT

GlobeNewswire

6 months ago

Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
ELUT

GlobeNewswire

6 months ago

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice
ELUT

GlobeNewswire

6 months ago

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

Elutia Confirms No Material Impact from Global Tariffs
ELUT

GlobeNewswire

7 months ago

Elutia Confirms No Material Impact from Global Tariffs

EluPro™ Named as 2025 Edison Award Winner
ELUT

GlobeNewswire

7 months ago

EluPro™ Named as 2025 Edison Award Winner

Elutia to Participate in Upcoming Investor Conferences
ELUT

GlobeNewswire

7 months ago

Elutia to Participate in Upcoming Investor Conferences

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes
ELUT

GlobeNewswire

7 months ago

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes

Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™
ELUT

GlobeNewswire

7 months ago

Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™

Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope
ELUT

GlobeNewswire

7 months ago

Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out
ELUT

GlobeNewswire

8 months ago

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out

Earnings To Watch: Elutia Inc (ELUT) Reports Q4 2024 Result
ELUT

GuruFocus.com

8 months ago

Earnings To Watch: Elutia Inc (ELUT) Reports Q4 2024 Result

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025
ELUT

GlobeNewswire

8 months ago

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

Private equity firms are Elutia Inc.'s (NASDAQ:ELUT) biggest owners and were hit after market cap dropped US$3.9m
ELUT

Simply Wall St.

9 months ago

Private equity firms are Elutia Inc.'s (NASDAQ:ELUT) biggest owners and were hit after market cap dropped US$3.9m

Elutia Announces $15.0 Million Registered Direct Offering
ELUT

GlobeNewswire

9 months ago

Elutia Announces $15.0 Million Registered Direct Offering

Elutia announces full U.S. commercial launch of EluPro
ELUT

TipRanks

10 months ago

Elutia announces full U.S. commercial launch of EluPro

Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand
ELUT

GlobeNewswire

10 months ago

Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand

Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners
ELUT

GlobeNewswire

10 months ago

Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.
ELUT

GlobeNewswire

a year ago

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

Elutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
ELUT

Simply Wall St.

a year ago

Elutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025
ELUT

GlobeNewswire

a year ago

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
ELUT

GlobeNewswire

a year ago

Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

What To Expect From Elutia Inc (ELUT) Q3 2024 Earnings
ELUT

GuruFocus.com

a year ago

What To Expect From Elutia Inc (ELUT) Q3 2024 Earnings

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024
ELUT

GlobeNewswire

a year ago

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30
ELUT

GlobeNewswire

a year ago

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

ELUT

ACCESSWIRE

a year ago

SWK Holdings Provides Portfolio Update

SILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia Inc
ELUT

GuruFocus.com

a year ago

SILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia Inc

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices
ELUT

GlobeNewswire

a year ago

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices

Elutia Celebrates First Year
ELUT

GlobeNewswire

a year ago

Elutia Celebrates First Year

Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators
ELUT

GlobeNewswire

a year ago

Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators

Elutia to Participate in Upcoming Investor Conferences
ELUT

GlobeNewswire

a year ago

Elutia to Participate in Upcoming Investor Conferences

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now
ELUT

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Elutia Announces Second Quarter 2024 Results
ELUT

GlobeNewswire

a year ago

Elutia Announces Second Quarter 2024 Results

Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds
ELUT

GlobeNewswire

a year ago

Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
ELUT

GlobeNewswire

a year ago

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations

Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
ELUT

GlobeNewswire

a year ago

Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
ELUT

ACCESSWIRE

a year ago

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
ELUT

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

Elutia to Present at the Emerging Growth Conference on Thursday, July 18
ELUT

GlobeNewswire

a year ago

Elutia to Present at the Emerging Growth Conference on Thursday, July 18

Individual investors in Elutia Inc. (NASDAQ:ELUT) are its biggest bettors, and their bets paid off as stock gained 16% last week
ELUT

Simply Wall St.

a year ago

Individual investors in Elutia Inc. (NASDAQ:ELUT) are its biggest bettors, and their bets paid off as stock gained 16% last week

Elutia Announces $13.26 Million Registered Direct Offering
ELUT

GlobeNewswire

a year ago

Elutia Announces $13.26 Million Registered Direct Offering

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators
ELUT

GlobeNewswire

a year ago

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024
ELUT

GlobeNewswire

a year ago

Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024

Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance
ELUT

GlobeNewswire

a year ago

Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance

Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
ELUT

GlobeNewswire

a year ago

Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

ELUT

ACCESSWIRE

2 years ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1
ELUT

GlobeNewswire

2 years ago

Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1

Elutia Full Year 2023 Earnings: Misses Expectations
ELUT

Simply Wall St.

2 years ago

Elutia Full Year 2023 Earnings: Misses Expectations

Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024
ELUT

GlobeNewswire

2 years ago

Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
ELUT

GlobeNewswire

2 years ago

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants
ELUT

News Direct

2 years ago

Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants

Analysts Estimate Regional Management (RM) to Report a Decline in Earnings: What to Look Out for
ELUT

Zacks

2 years ago

Analysts Estimate Regional Management (RM) to Report a Decline in Earnings: What to Look Out for

Bank7 Corp. (NASDAQ:BSVN) Q4 2023 Earnings Call Transcript
ELUT

Insider Monkey

2 years ago

Bank7 Corp. (NASDAQ:BSVN) Q4 2023 Earnings Call Transcript

ELUT

GuruFocus.com

2 years ago

FVCBankcorp Inc (FVCB) Reports Mixed Results Amidst Strategic Repositioning

FVCBankcorp (FVCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
ELUT

Zacks

2 years ago

FVCBankcorp (FVCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago
ELUT

Simply Wall St.

2 years ago

Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago

Why WW International Stock Bounced 6% Higher Today
ELUT

Motley Fool

2 years ago

Why WW International Stock Bounced 6% Higher Today

Radcom (RDCM) Surges 5.4%: Is This an Indication of Further Gains?
ELUT

Zacks

2 years ago

Radcom (RDCM) Surges 5.4%: Is This an Indication of Further Gains?

Q1’s Rising Stars: 3 Lithium Stocks for Your Must-Watch List
ELUT

InvestorPlace

2 years ago

Q1’s Rising Stars: 3 Lithium Stocks for Your Must-Watch List

Elutia Regains Compliance with Nasdaq Listing Requirements
ELUT

GlobeNewswire

2 years ago

Elutia Regains Compliance with Nasdaq Listing Requirements

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
ELUT

GlobeNewswire

2 years ago

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

AvePoint to Participate in 26th Annual Needham Growth Conference
ELUT

GlobeNewswire

2 years ago

AvePoint to Participate in 26th Annual Needham Growth Conference

CarParts.com, Inc. (NASDAQ:PRTS) is a favorite amongst institutional investors who own 62%
ELUT

Simply Wall St.

2 years ago

CarParts.com, Inc. (NASDAQ:PRTS) is a favorite amongst institutional investors who own 62%

Better Risky Investment: Bluebird Bio vs. Shiba Inu
ELUT

Motley Fool

2 years ago

Better Risky Investment: Bluebird Bio vs. Shiba Inu

Analysts Expect Breakeven For AvePoint, Inc. (NASDAQ:AVPT) Before Long
ELUT

Simply Wall St.

2 years ago

Analysts Expect Breakeven For AvePoint, Inc. (NASDAQ:AVPT) Before Long

Endeavour Silver Announces At-the-Market Offering of up to US$60 Million
ELUT

GlobeNewswire

2 years ago

Endeavour Silver Announces At-the-Market Offering of up to US$60 Million

12 High Growth Utility Stocks to Buy
ELUT

Insider Monkey

2 years ago

12 High Growth Utility Stocks to Buy

Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance
ELUT

GlobeNewswire

2 years ago

Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance

Insider Sell Alert: Director Terry Vance Sells 15,295 Shares of Enanta Pharmaceuticals Inc (ENTA)
ELUT

GuruFocus.com

2 years ago

Insider Sell Alert: Director Terry Vance Sells 15,295 Shares of Enanta Pharmaceuticals Inc (ENTA)

Climb Channel Solutions Expands Malwarebytes Partnership to North America, Providing MSPs and Resellers with Award-Winning Endpoint Security
ELUT

GlobeNewswire

2 years ago

Climb Channel Solutions Expands Malwarebytes Partnership to North America, Providing MSPs and Resellers with Award-Winning Endpoint Security

Townsquare To Participate In Upcoming Investor Conferences
ELUT

GlobeNewswire

2 years ago

Townsquare To Participate In Upcoming Investor Conferences

VIZSLA SILVER REPORTS ADDITIONAL HIGH-GRADE INTERCEPTS ON THE COPALA AND COPALA 2 STRUCTURES
ELUT

CNW Group

2 years ago

VIZSLA SILVER REPORTS ADDITIONAL HIGH-GRADE INTERCEPTS ON THE COPALA AND COPALA 2 STRUCTURES

Silence Therapeutics plc's (NASDAQ:SLN) 65% Price Boost Is Out Of Tune With Revenues
ELUT

Simply Wall St.

2 years ago

Silence Therapeutics plc's (NASDAQ:SLN) 65% Price Boost Is Out Of Tune With Revenues

NuScale Power to Collaborate with Oak Ridge National Laboratory for a Techno-Economic Assessment
ELUT

Business Wire

2 years ago

NuScale Power to Collaborate with Oak Ridge National Laboratory for a Techno-Economic Assessment

Atomera Achieves Revenue Milestone Under First Commercial License Agreement
ELUT

ACCESSWIRE

2 years ago

Atomera Achieves Revenue Milestone Under First Commercial License Agreement

Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results
ELUT

GlobeNewswire

2 years ago

Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES
ELUT

CNW Group

2 years ago

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES

Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
ELUT

GlobeNewswire

2 years ago

Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

Docebo Reports Third Quarter 2023 Results
ELUT

Business Wire

2 years ago

Docebo Reports Third Quarter 2023 Results

ELUT

Associated Press Finance

2 years ago

Kandi Tech: Q3 Earnings Snapshot

ELUT

GlobeNewswire

2 years ago

Kandi Technologies Reports Third Quarter 2023 Financial Results

Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
ELUT

GlobeNewswire

2 years ago

Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023

Tile Shop Holdings, Inc. (NASDAQ:TTSH) Q3 2023 Earnings Call Transcript
ELUT

Insider Monkey

2 years ago

Tile Shop Holdings, Inc. (NASDAQ:TTSH) Q3 2023 Earnings Call Transcript

New Report: Virtual Events Surpass Both Hybrid and In-Person Events
ELUT

GlobeNewswire

2 years ago

New Report: Virtual Events Surpass Both Hybrid and In-Person Events

Share on Social Networks: